Anti-IL-5Ra/ CD125 Antibody (Benralizumab)
Catalog No.
F1214
Anti-IL-5Ra/ CD125 Antibody (Benralizumab)
Featured Products
Benralizumab (MEDI-563) is an interleukin 5 receptor alpha (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils by enhancing antibody-dependent cell-mediated cytotoxicity. All. Benralizumab is indicated for severe eosinophilic asthma.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.06 kDa
Dry ice
1044511-01-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Fasenra, MEDI-563, BIW-8405
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q01344
Human, Mouse, Rat
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL 5Rα His at 2 ug/mL can bind Anti-IL-5Ra/ CD125 Antibody (Benralizumab)
IL-5Ra/ CD125
Please avoid freeze-thaw cycles.